EURASIAN PHARMACEUTICAL FORUM (2-4 March 2021HYBRID)
What challenges did your company face in 2020 and what did you achieve? How has the pharmaceutical market in the EAEU and CIS countries been affected by the COVID-19 pandemic? How has it affected business processes and the industry in general? Which strategies will be the most effective in the coming decade?